Aspergillosis Therapeutics - Pipeline Assessment and

Market Forecasts to 2019

On 11thDecember 2014

Summary
The industry analysis specialist, has released its new report, Aspergillosis Therapeutics Pipeline Assessment and Market Forecasts to 2019. The report is an essential source of
information and analysis on the global Aspergillosis Therapeutics market. The report identifies
the key trends shaping and driving the global Aspergillosis Therapeutics market. The report also
provides insights on the prevalent competitive landscape and the emerging players expected to
significantly alter the market positioning of the current market leaders. Most importantly, the
report provides valuable insights on the pipeline products within the global Aspergillosis
Therapeutics sector. This report is built using data and information sourced from proprietary
databases, primary and secondary research and in-house analysis by GlobalDatas team of
industry experts.

You can buy this Report @ http://www.jsbmarketresearch.com/healthcaremedical/r-aspergillosis-therapeutics-pipeline-assessment-and-market-forecasts135200

Scope
The report provides information on the key drivers and challenges of the Aspergillosis
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Therapeutics market. Its scope includes - Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Aspergillosis
Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being
developed and emerging trends by seven key markets. Pipeline candidates fall under major
therapeutic classes.
- Analysis of the current and future competition in the seven key countries Aspergillosis
Therapeutics market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is
independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet
needs and the implications for the Aspergillosis Therapeutics market.
- Analysis of key recent licensing and partnership agreements in Aspergillosis Therapeutics
market

Reasons to buy
The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline
products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global
Aspergillosis Therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies,
market segments and companies likely to impact the global Aspergillosis Therapeutics market in
future.
- Formulate effective sales and marketing strategies by understanding the competitive
landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective
counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments
that present maximum opportunities for consolidations, investments and strategic
partnerships.
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

- Whats the next big thing in the global Aspergillosis Therapeutics market landscape?
Identify, understand and capitalize.

Other industries we cover:

Advertising and Media

Automotive and Parts
Consumer Goods
Healthcare and Medical
Finance and Banking
Food and Beverages
Travel and Tourism
Textiles and Clothing
SWOT Analysis

Discounts on Market Research Reports till 31st December, 2014

For more inquiries, contact at +91 - 998 729 5242 /
contact@jsbmarketresearch.com

Table of Content
2 Aspergillosis Therapeutics - Introduction
2.1 Overview
2.2 Epidemiology
2.3 Etiology
2.4 Symptoms
2.5 Diagnosis
2.6 Pathophysiology
2.7 Treatment and Management Pattern
2.8 GlobalData Pipeline Report Guidance
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

3 Aspergillosis Therapeutics - Market Characterization

3.1 Overview
3.2 Aspergillosis Therapeutics Market Size (2006-2011) - Global
3.3 Aspergillosis Therapeutics Market Forecast (2011-2019) - Global
3.4 Aspergillosis Therapeutics Market Size (2006-2011) - The US
3.5 Aspergillosis Therapeutics Market Forecast (2011-2019) - The US
3.6 Aspergillosis Therapeutics Market Size (2006-2011) - France
3.7 Aspergillosis Therapeutics Market Forecast (2011-2019) - France
3.8 Aspergillosis Therapeutics Market Size (2006-2011) - Germany
3.9 Aspergillosis Therapeutics Market Forecast (2011-2019) - Germany
3.10 Aspergillosis Therapeutics Market Size (2006-2011) - Italy
3.11 Aspergillosis Therapeutics Market Forecast (2011-2019) - Italy
3.12 Aspergillosis Therapeutics Market Size (2006-2011) - Spain
3.13 Aspergillosis Therapeutics Market Forecast (2011-2019) - Spain
3.14 Aspergillosis Therapeutics Market Size (2006-2011) - The UK
3.15 Aspergillosis Therapeutics Market Forecast (2011-2019) - The UK
3.16 Aspergillosis Therapeutics Market Size (2006-2011) - Japan
3.17 Aspergillosis Therapeutics Market Forecast (2011-2019) - Japan
3.18 Drivers and Barriers for the Aspergillosis Therapeutics Market
3.18.1 Drivers for the Aspergillosis Therapeutics Market
3.18.2 Barriers for the Aspergillosis Therapeutics Market
3.19 Opportunity and Unmet Need
3.20 Key Takeaway
4 Aspergillosis Therapeutics Market - Competitive Assessment
4.1 Overview
4.2 Strategic Competitor Assessment
4.3 Product Profiles of the Major Marketed Products in the Aspergillosis Therapeutics Market Heparin Class
4.3.1 Voriconazole (Vfend)
4.3.2 Posaconazole (Noxafil)
4.3.3 Itraconazole (Sporanox)
4.3.4 Caspofungin (Cancidas)
4.3.5 Amphotericin B (Amphocin)
4.4 Key Takeaway
5 Aspergillosis Therapeutics Market - Pipeline Assessment
5.1 Overview
5.1.1 Aspergillosis Therapeutics - Phase III Clinical Pipeline
5.1.2 Aspergillosis Therapeutics - Phase II Clinical Pipeline
5.1.3 Aspergillosis Therapeutics - Phase I Clinical Pipeline
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

5.1.4 Aspergillosis Therapeutics - Preclinical and Discovery Clinical Pipeline

5.2 Aspergillosis Therapeutics Market - Pipeline Assessment by Mechanism of Action
5.3 Aspergillosis Therapeutics Market - Technology Trends Analytical Framework
5.4 Aspergillosis Therapeutics Market - Pipeline Assessment by Clinical Phase of Development
5.5 Molecule Profile for Drugs under Clinical Development
5.5.1 Isavuconazole
5.5.2 SPK-843
5.6 Key Takeaway
6 Aspergillosis Therapeutics - Clinical Trials Mapping
6.1 Clinical Trials by Region/Country
6.2 Clinical Trials by Phase of Clinical Development
6.3 Clinical Trials by Trial Status
6.4 Prominent and Overall Sponsors
6.5 Brief Profiles of Top 10 Companies Participating in Clinical Trials
7 Aspergillosis Therapeutics - Strategic Assessment
7.1 Key Events Impacting the Future Market
7.2 Future Market Competition Scenario
8 Aspergillosis Therapeutics - Future Players
8.1 Introduction
8.2 Company Profiles
8.2.1 Pfizer Inc.
8.2.2 Astellas Pharma Inc.
8.2.3 Basilea Pharmaceutica Ltd. (Basilea)
9 Aspergillosis Therapeutics - Acquisition Deals
10 Aspergillosis Therapeutics Market - Appendix
10.1 Market Definition
10.2 Abbreviations
10.3 Methodology
10.3.1 Coverage
10.3.2 Secondary Research
10.3.3 Forecasting
10.3.4 Primary Research
10.3.5 Expert Panel Validation
10.4 Contact Us
10.5 Disclaimer
10.6 Bibliography

Email ID- contact@jsbmarketresearch.com

Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

List Of Tables
Table 1: Aspergillosis Therapeutics Market, Global, Revenues ($m), 2006-2011
Table 2: Aspergillosis Therapeutics Market, Global, Market Forecasts ($m), 2011-2019
Table 3: Aspergillosis Therapeutics Market, The US, Revenue ($m), 2006-2011
Table 4: Aspergillosis Therapeutics Market, The US, Market Forecasts ($m), 2011-2019
Table 5: Aspergillosis Therapeutics Market, France, Revenue ($m), 2006-2011
Table 6: Aspergillosis Therapeutics Market, France, Market Forecast ($m), 2011-2019
Table 7: Aspergillosis Therapeutics Market, Germany, Revenue ($m), 2006-2011
Table 8: Aspergillosis Therapeutics Market, Germany, Market Forecast ($m), 2011-2019
Table 9: Aspergillosis Therapeutics Market, Italy, Revenue ($m), 2006-2011
Table 10: Aspergillosis Therapeutics Market, Italy, Market Forecast ($m), 2011-2019
Table 11: Aspergillosis Therapeutics Market, Spain, Revenue ($m), 2006-2011
Table 12: Aspergillosis Therapeutics Market, Spain, Market Forecast ($m), 2011-2019
Table 13: Aspergillosis Therapeutics Market, The UK, Revenue ($m), 2006-2011
Table 14: Aspergillosis Therapeutics Market, The UK, Market Forecast ($m), 2011-2019
Table 15: Aspergillosis Market, Japan, Revenue ($m), 2006-2011
Table 16: Aspergillosis Therapeutics Market, Japan, Market Forecast ($m), 2011-2019
Table 17: Aspergillosis Therapeutics Market - Phase III Clinical Pipeline, 2010
Table 18: Aspergillosis Therapeutics Market - Phase II Clinical Pipeline, 2010
Table 19: Aspergillosis Therapeutics Market - Phase I Clinical Pipeline, 2010
Table 20: Aspergillosis Therapeutics Market - Preclinical Pipeline, 2010
Table 21: Aspergillosis Market, Global, Clinical Trials by Country, 2010
Table 22: Aspergillosis Market, Global, Clinical Trials by Phase, 2010
Table 23: Aspergillosis Market, Global, Clinical Trials by Status of Development, 2010
Table 24: Aspergillosis Market, Global, Sponsors, 2010
Table 25: Aspergillosis Market, Global, Companies by Phase, 2010
Table 26: Aspergillosis Therapeutics, Global, Deals, 2011

List Of Figures
Figure 1: Aspergillosis Therapeutics Market, Global, Revenues ($m), 2006-2011
Figure 2: Aspergillosis Therapeutics Market, Global, Market Forecast ($m), 2011-2019
Figure 3: Aspergillosis Therapeutics Market, The US, Revenue ($m), 2006-2011
Figure 4: Aspergillosis Therapeutics Market, The US, Market Forecasts ($m), 2011-2019
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Figure 5: Aspergillosis Therapeutics Market, France, Revenue ($m), 2006-2011

Figure 6: Aspergillosis Therapeutics Market, France, Market Forecast ($m), 2011-2019
Figure 7: Aspergillosis Therapeutics Market, Germany, Revenue ($m), 2006-2011
Figure 8: Aspergillosis Therapeutics Market, Germany, Market Forecast ($m), 2011-2019
Figure 9: Aspergillosis Therapeutics Market, Italy, Revenue ($m), 2006-2011
Figure 10: Aspergillosis Therapeutics Market, Italy, Market Forecast ($m), 2011-2019
Figure 11: Aspergillosis Therapeutics Market, Spain, Revenue ($m), 2006-2011
Figure 12: Aspergillosis Therapeutics Market, Spain, Market Forecast ($m), 2011-2019
Figure 13: Aspergillosis Therapeutics Market, The UK, Revenue ($m), 2006-2011
Figure 14: Aspergillosis Therapeutics Market, The UK, Market Forecast ($m), 2011-2019
Figure 15: Aspergillosis Therapeutics Market, Japan, Revenue ($m), 2006-2011
Figure 16: Aspergillosis Therapeutics Market, Japan, Market Forecast ($m), 2011-2019
Figure 17: Opportunity and Unmet Need in the Aspergillosis Therapeutics Market
Figure 18: Strategic Competitor Assessment of the Marketed Products for Aspergillosis, 2010
Figure 19: Aspergillosis Therapeutics Market - Clinical Pipeline by Mechanism of Action, 2010
Figure 20: Technology Trends Analytic Framework of the Aspergillosis Pipeline, 2010
Figure 21: Technology Trends Analytic Framework of the Aspergillosis Pipeline - Description,
2010
Figure 22: Aspergillosis Pipeline by Phase of Clinical Development, 2010
Figure 23: Aspergillosis Market, Global, Clinical Trials by Country, 2010
Figure 24: Aspergillosis Market, Global, Clinical Trials by Phase, 2010
Figure 25: Aspergillosis Market, Global, Clinical Trials by Stage of Development, 2010
Figure 26: Aspergillosis Market, Global, Prominent Sponsors, 2010
Figure 27: Aspergillosis Market, Global, Overall Sponsors, 2010
Figure 28: Aspergillosis, Market, Global, Companies by Phase, 2010
Figure 29: Aspergillosis Market, Drivers and Barriers, 2010
Figure 30: Implications for Future Market Competition in the Aspergillosis Therapeutics Market,
2011
Figure 31: Aspergillosis Therapeutics Market - Clinical Pipeline by Company, 2010
Figure 32: GlobalData Market Forecasting Model

Email ID- contact@jsbmarketresearch.com

Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Report Price:
Licence Type

Price

PDF

$ 3995

Site Licence

$ 7990

Enterprise Wide Licence

$ 11985

Related Reports:
Haemophilus Influenzae Type B (Hib) Vaccine - Pipeline Assessment and Market Forecasts to 2019
Hepatitis B Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Methicillin-resistant Staphylococcus aureus (MRSA) Therapeutics - Pipeline Assessment and Market
Forecasts to 2019
Atherosclerosis or Coronary Artery Disease (CAD) Therapeutics - Pipeline Assessment and Market
Forecasts to 2018
Unstable Angina Therapeutics - Pipeline Assessment and Market Forecast to 2018
Venous Thromboembolism (VTE) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
Pulmonary Embolism (PE) Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Vitiligo Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Chronic Urticaria or Hives Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Peptic Ulcer Therapeutics- Pipeline Assessment and Market Forecasts to 2018

Email ID- contact@jsbmarketresearch.com

Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

You can order this report by calling on +91 - 998 7295 242 or mail us
your contact details at contact@jsbmarketresearch.com

About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is onestop-shop for all information related to market research for any sector of the industry. Along
with providing in-depth analysis though reports, JSB market research also provides regular
updates of the market though newsletters. Our reports are a well-researched work of market
researchers with an extensive knowledge and a good level of market experience.

To know more on Aspergillosis Therapeutics - Pipeline Assessment and Market

Forecasts to 2019
http://www.jsbmarketresearch.com/healthcare-medical/r-aspergillosistherapeutics-pipeline-assessment-and-market-forecasts-135200

Email ID- contact@jsbmarketresearch.com

Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/